Array BioPharma, Inc. (NASDAQ:ARRY)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life threatening and debilitating diseases.

Results 1 - 20 of 30 : 1 2 Next »

Recs

0
Member Avatar bIlluminati (29.97) Submitted: 7/25/2014 3:54:57 PM : Underperform Start Price: $4.18 ARRY Score: -1.89

Margins too low.

Recs

0
Member Avatar TerryFool (< 20) Submitted: 3/25/2014 5:50:51 AM : Outperform Start Price: $4.18 ARRY Score: -4.18

BUY@ 4.4 TP 8

Recs

0
Member Avatar TerryHoodSr (48.03) Submitted: 3/24/2014 6:50:19 PM : Outperform Start Price: $4.40 ARRY Score: -7.82

SPEC BUY@ 4.4 TP 8

Recs

0
Member Avatar stockanal45 (29.87) Submitted: 11/29/2013 5:57:06 PM : Outperform Start Price: $4.98 ARRY Score: -24.38

Strong breakthrough pipelines

Recs

1
Member Avatar zzlangerhans (99.75) Submitted: 8/28/2013 11:56:36 PM : Outperform Start Price: $5.55 ARRY Score: -43.63

I dread my quarterly updates of Array because it's so time-consuming to review all the trials in progress from their extremely wide pipeline. There's certainly something to be said from having a lot of shots on goal, but as we've seen with Exelixis more isn't necessarily better. I'll take a leap here despite the ballooning of market cap over the last year as partners AstraZeneca and Novartis have pushed Array's drugs into phase III trials and Portefeuille has induced me to purchase 1000 shares at 6.29 for zzporte.

Recs

0
Member Avatar rknapton (< 20) Submitted: 7/23/2013 8:22:55 PM : Underperform Start Price: $6.15 ARRY Score: +47.09

Short. Biopharma. Revs down 47%. Negative EBIT and large interest expense. Tons and tons of raising $ by issuing more shares.

Recs

0
Member Avatar bichon2 (66.96) Submitted: 3/6/2013 11:59:45 AM : Outperform Start Price: $4.32 ARRY Score: -29.61

Great drug to treat braf mutation cancers. Also good results in multiple myeloma .

Recs

0
Member Avatar CarlosDK (21.16) Submitted: 1/23/2013 7:57:05 AM : Underperform Start Price: $3.99 ARRY Score: +25.78

TOS: TOP HS pattern

Recs

0
Member Avatar tesst (< 20) Submitted: 2/7/2012 3:42:20 PM : Outperform Start Price: $3.29 ARRY Score: -17.04

Has bottomed and it is all up from here

Recs

0
Member Avatar solanZRaider (< 20) Submitted: 4/26/2011 3:19:12 PM : Outperform Start Price: $3.06 ARRY Score: -7.47

Momentum21 & usubanas

Recs

0
Member Avatar rocknpopstocks (< 20) Submitted: 1/28/2011 12:32:42 PM : Outperform Start Price: $2.82 ARRY Score: -3.15

Could show serious growth of this decade.

Recs

0
Member Avatar cprpm (< 20) Submitted: 10/13/2010 4:09:59 PM : Outperform Start Price: $3.53 ARRY Score: -47.07

Array has been able to survive the toughest of times, I feel it's matter of time.

Recs

2
Member Avatar 21popsontop (< 20) Submitted: 1/28/2010 10:21:53 AM : Outperform Start Price: $2.51 ARRY Score: -11.35

Has always had that longshot look, and now we see the big boys taking them out for dinner and paying for friendship, advise and technology expertise. Looks much better than DNDN for sure and even has real products on the market and several more in the oven. One to watch.

Recs

1
Member Avatar lola99999 (< 20) Submitted: 12/16/2009 9:33:21 PM : Outperform Start Price: $2.57 ARRY Score: -12.82

ARRY

Recs

4
Member Avatar redwings103149 (< 20) Submitted: 9/15/2009 11:03:37 PM : Outperform Start Price: $2.84 ARRY Score: -37.19

What a great price to get into this stock. Well little history on arry was that they have had a hugeeee pipeline but have been blessed with some terrible along with a trial 3 data result that did not meet its ends. Away from the bad they have four game changers due within the next 6months so spec alone will hype this baby up eventually.

Recs

1
Member Avatar shinier (< 20) Submitted: 9/10/2009 6:31:14 PM : Outperform Start Price: $2.83 ARRY Score: -38.64

Loss-making, but these small pharma's are a gamble. One hit is all it takes.

Recs

1
Member Avatar GrandTheftHemi (< 20) Submitted: 5/7/2009 9:57:48 PM : Outperform Start Price: $3.12 ARRY Score: -80.39

At lower end of trading range with possible DRIVERS coming in Summer of 2009. 4.75 a share would make me smile but anything higher would make me Happy...not a bad company as BIOS go.

Recs

2
Member Avatar TheBigLab (71.65) Submitted: 5/5/2009 1:03:23 PM : Outperform Start Price: $3.07 ARRY Score: -82.27

Bio is the next big run after financials and alt energy....its coming.

Recs

1
Member Avatar rxedoh26 (71.07) Submitted: 1/31/2009 10:28:16 PM : Outperform Start Price: $3.94 ARRY Score: -138.26

going up eventually

Recs

1
Member Avatar TMFBiologyFool (96.93) Submitted: 10/13/2008 5:43:44 PM : Outperform Start Price: $5.14 ARRY Score: -110.63

Good pipeline. Market is overrating the risk.

Results 1 - 20 of 30 : 1 2 Next »

Featured Broker Partners


Advertisement